FDA regulations
- XTANT Medical Holdings, Inc: nanOss 3D Advanced Bone Graft Substitute nanOss 3D Plus Advanced Bone Graft Substitute 90-300-251008: nanOss 3D Advanced Bone Graft Substitute, 25x100x8mm, 20cc 90...April 29, 2026
XTANT Medical Holdings recalls 225 units of nanOss 3D Advanced Bone Graft Substitute nationwide due to incorrect 5-year shelf-life labeling when validated shelf life is four years.
- AI-Enabled Optimization of Early-Phase Clinical Trials Pilot Program; Request for InformationApril 29, 2026
FDA seeks input on a pilot program to evaluate AI-enabled technologies for improving efficiency and decision-making in early-phase clinical trials while maintaining regulatory standards.
- Ghirardelli Chocolate Company Recalls Powdered Beverage Mixes Because of Possible Health Risk
Track FDA regulations for your business
Tell Bizmoon what your business does and we'll cut the Food and Drug Administration rulings down to what actually matters.
Action items + deadlines
Every rule is broken into specific to-dos with calendar dates.
Affected areas
We tell you which parts of your business each rule actually touches.
Plain-English summaries